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were classified based only on persistence of effects, with 
the remaining being classified mostly based on severe cor-
neal effects. Iritis was found to rarely drive the classifica-
tion (<4 % of both Cat 1 and Cat 2 chemicals). The two 
most important endpoints driving Cat 2 classification are 
conjunctiva redness (75–81 %) and corneal opacity (54–
75 %). The resampling analyses demonstrated an overall 
probability of at least 11 % that chemicals classified as 
Cat 1 by the Draize eye test could be equally identified as 
Cat 2 and of about 12 % for Cat 2 chemicals to be equally 
identified as No Cat. On the other hand, the over-classifi-
cation error for No Cat and Cat 2 was negligible (<1 %), 
which strongly suggests a high over-predictive power of the 
Draize eye test. Moreover, our analyses of the classification 
drivers suggest a critical revision of the UN GHS/EU CLP 
decision criteria for the classification of chemicals based 
on Draize eye test data, in particular Cat 1 based only on 
persistence of conjunctiva effects or corneal opacity scores 
Abstract For more than two decades, scientists have 
been trying to replace the regulatory in vivo Draize eye test 
by in vitro methods, but so far only partial replacement has 
been achieved. In order to better understand the reasons for 
this, historical in vivo rabbit data were analysed in detail 
and resampled with the purpose of (1) revealing which of 
the in vivo endpoints are most important in driving United 
Nations Globally Harmonized System/European Union 
Regulation on Classification, Labelling and Packaging (UN 
GHS/EU CLP) classification for serious eye damage/eye 
irritation and (2) evaluating the method’s within-test vari-
ability for proposing acceptable and justifiable target values 
of sensitivity and specificity for alternative methods and 
their combinations in testing strategies. Among the Cat 1 
chemicals evaluated, 36–65 % (depending on the database) 
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of 4. In order to successfully replace the regulatory in vivo 
Draize eye test, it will be important to recognise these 
uncertainties and to have in vitro tools to address the most 
important in vivo endpoints identified in this paper.
Keywords UN GHS/EU CLP · Drivers of classification · 
Eye irritation/serious eye damage · Draize within-test 
variability · Validation of in vitro methods
List of abbreviations
BCOP  Bovine Corneal Opacity and Permeability
CAMVA  Chorioallantoic Membrane Vascular Assay
Cat 1  UN GHS/EU CLP classification for chemi-
cals causing irreversible effects on the eye/
serious damage to the eye
Cat 2  UN GHS/EU CLP classification for chemi-
cals causing reversible effects on the eye/eye 
irritation
CC  Conjunctiva chemosis
CCMaj  Corresponds to the second highest (for stud-
ies with 3 or 4 animals) or the third highest 
(for studies with 5 or 6 animals) of the mean 
CC scores (of gradings at 24, 48, and 72 h)
CO  Corneal opacity
COMaj  Corresponds to the second highest (for stud-
ies with 3 or 4 animals) or the third highest 
(for studies with 5 or 6 animals) of the mean 
CO scores (of gradings at 24, 48, and 72 h)
CR  Conjunctiva redness
CRMaj  Corresponds to the second highest (for stud-
ies with 3 or 4 animals) or the third highest 
(for studies with 5 or 6 animals) of the mean 
CR scores (of gradings at 24, 48, and 72 h)
Ex-ECB  Ex-European Chemicals Bureau
ECETOC  Eye Irritation Reference Chemicals Data 
Bank
EIT  Eye Irritation Test
EU CLP  European Union Regulation on Classifica-
tion, Labelling and Packaging of chemicals 
implementing UN GHS in the EU
EVEIT  Ex-Vivo Eye Irritation Test
FL  Fluorescein Leakage
HCE  Human Corneal Epithelium
HET-CAM  Hen’s Egg Test–Chorioallantoic Membrane
ICCVAM  Interagency Coordinating Committee on the 
Validation of Alternative Methods
ICE  Isolated Chicken Eye
IR  Iritis
IRMaj  Corresponds to the second highest (for stud-
ies with 3 or 4 animals) or the third highest 
(for studies with 5 or 6 animals) of the mean 
IR scores (of gradings at 24, 48, and 72 h)
LNS  Laboratoire National de la Santé
NCD  European New Chemicals Database
No Cat  Chemicals not classified for serious eye dam-
age/eye irritation under UN GHS/EU CLP
OECD  Organisation for Economic Co-operation and 
Development
PorCORA  Porcine Corneal Ocular Reversibility Assay
RCD  Reference Chemicals Databases
RhT  Reconstructed human Tissue
UN GHS  United Nations Globally Harmonized System 
of Classification and Labelling of Chemicals
Introduction
The serious eye damage/eye irritation test developed by 
Draize et al. (1944) has been for over half a century the ref-
erence method for ocular hazard identification. However, 
several in vitro methods for assessing the serious eye dam-
age/eye irritation potential of chemicals have been devel-
oped as alternatives to the Draize eye test. Currently, only 
three methods are adopted by the Organisation for Eco-
nomic Co-operation and Development (OECD) as partial 
replacements to classify chemicals as inducing serious eye 
damage (UN GHS/EU CLP Category 1). These are two 
organotypic assays, the Bovine Corneal Opacity and Per-
meability (BCOP) test method (OECD TG 437) and the 
Isolated Chicken Eye (ICE) test method (OECD TG 438) 
(OECD 2013a, b), and a cell-based assay, the Fluorescein 
Leakage (FL) test method (OECD TG 460) (OECD 2012b). 
In addition, two of these methods (BCOP and ICE) were 
recently adopted by the OECD for the identification of 
chemicals not requiring a classification for serious eye dam-
age/eye irritation (UN GHS/EU CLP No Category) (OECD 
2013a, b). Two other test methods, namely the Cytosensor 
Microphysiometer (CM) (Hartung et al. 2010) and the Short-
Time Exposure (STE) (Takahashi et al. 2008, 2009; Sakagu-
chi et al. 2011), are currently under the process of regulatory 
acceptance by the OECD for the identification of both UN 
GHS/EU CLP Category 1 and No Category chemicals, with 
limited applicability domains (ESAC 2009; ICCVAM 2013). 
However, no single in vitro method or combination of meth-
ods has yet been successfully validated for full replacement 
of the in vivo Draize eye test (Scott et al. 2010).
Accurate analyses of the in vivo Draize eye test data are 
important for several reasons. The outcome of validation 
studies depends not only on the performance of the in vitro 
method but also on the quality and variability of the in vivo 
data that usually serve as a reference point for compari-
son, in the absence of standardised human data. Chemicals 
that do not have reliable in vivo data of sufficient quality 
should not be selected as reference chemicals. It is therefore 
imperative that the quality of the in vivo data is carefully 
assessed, so that a robust selection of candidate chemicals 
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for validation studies can be made. The impact of the vari-
ability of the in vivo Draize eye test, including inter alia 
the “in vivo within-test variability”, on the final classifica-
tion of a chemical is another important issue for the selec-
tion of reference chemicals. With increasing variability, the 
uncertainty about the result increases. Therefore, it is not 
desirable to select chemicals with highly variable in vivo 
results to benchmark data in the validation of in vitro meth-
ods. Moreover, the determination of the most relevant in 
vivo endpoint(s), in particular the effects on cornea, iris or 
conjunctiva, is extremely important for the development of 
adequate in vitro methods and will allow better understand-
ing of the relationship between the in vitro and the in vivo 
data. Such an analysis can also provide valuable informa-
tion on the usefulness and limitations of the in vitro assays, 
for example by clarifying which ocular endpoints the alter-
native methods are able to predict. Ultimately, a thorough 
analysis of animal reference data allows taking into account 
the imperfectness of accepted reference test methods in the 
assessment of new alternative test methods developed to 
replace them.
The present study reports a detailed statistical analysis 
and resampling of historical in vivo Draize eye test data, 
performed with the purpose of (1) determining the most 
important tissue effect(s) (corneal opacity, iritis, conjunc-
tiva chemosis, conjunctiva redness) for the classification of 
chemicals in vivo according to the United Nations Glob-
ally Harmonized System of Classification and Labelling of 
Chemicals (UN GHS) (UN 2013) and the European Union 
Regulation on Classification, Labelling and Packaging of 
chemicals (EU CLP) implementing UN GHS in the EU 
(EC 2008), (2) determining the importance of irreversibil-
ity of ocular effects for classification of chemicals in vivo 
(e.g. proportion of chemicals classified on the basis of per-
sistence of effects), (3) evaluating the test method’s within-
test variability based on the current data interpretation pro-
cedures, and (4) proposing acceptable and justifiable target 
values of sensitivity and specificity for alternative methods 
and their combinations in testing strategies. The historical 
in vivo Draize eye test data used in this work originated 
from several sources including many industry sectors, and 
no new in vivo data were generated to perform the analyses. 
These data were obtained from (1) three Reference Chemi-
cals Databases (RCD) containing data mostly on “existing 
chemicals” (on the EU industrial market before 1981) and 
(2) from the European New Chemicals Database (NCD) 
of the ex-European Chemicals Bureau (ex-ECB) con-
taining data on “new chemicals” notified under Directive 
67/548/EEC (introduced to the EU industrial market after 
September 1981). The RCD contains commercially avail-
able chemicals that have been commonly used in validation 
studies of in vitro methods and for which full in vivo Draize 
eye test data are available. The NCD, on the other hand, 
contains proprietary chemicals that have not been com-
monly used in validation studies, includes more complex 
chemistries and contains only summarised in vivo Draize 
eye test data. Since data in RCD and NCD may inherently 
differ, potentially with confounding factors, separate analy-
ses were performed on these two sets of data.
Materials and methods
Databases
The in vivo rabbit eye irritation data were collected from 
data registered in the NCD of the ex-ECB and three Refer-
ence Chemicals Databases (RCD), i.e. (1) the Eye Irrita-
tion Reference Chemicals Data Bank (ECETOC) (Bagley 
et al. 1992a, 1999a; ECETOC 1998), (2) the database from 
ZEBET (Spielmann et al. 1996), and (3) the database from 
Laboratoire National de la Santé (LNS) (Gautheron et al. 
1992). Before starting exploratory data analysis, a quality 
check of the Draize eye test data was performed. Studies 
Table 1  Draize eye studies from various data sources
RCD Reference Chemicals Databases, NCD European New Chemicals Database
a
 (i) if study criteria allowing an unambiguous classification were not met (SCNM), (ii) if less than three animals were used and no severe and/
or persistent effects were observed, (iii) in case of incomplete data or (iv) in case chemicals were classified in the absence of a classification trig-
gering effect (i.e. not based on a second (n = 3 or 4) or third (n = 5 or 6) highest animal mean tissue score above the classification threshold or 
on persistence of an effect) and the reason of classification was not indicated
Data source Number of studies UN GHS/EU CLP (proportion of valid stud-
ies)
Total Excludeda Valid No Cat Cat 2 Cat 1
RCD 1—ECETOC 149 12 137 56.2 18.2 25.5
RCD 2—ZEBET 143 55 88 61.4 14.8 23.9
RCD 3—LNS 52 3 49 69.4 18.4 12.2
RCD—Total 344 70 274 60.2 17.2 22.6
NCD—Total 2,319 459 1,860 82.6 10.4 6.9
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were excluded from the final analysis if (1) the study crite-
ria allowing an unambiguous classification were not met 
(SCNM), i.e. studies of less than 21 days where full revers-
ibility (scores equal to zero) of all endpoints in all animals 
did not occur and no severe effects were observed, (2) less 
than three animals were used and no severe and/or persistent 
effects were observed, (3) data were incomplete, i.e. missing 
data for at least one endpoint or no individual data accessi-
ble (NCD n > 3 animals), or (4) classification in the original 
database occurred without a tissue score above the threshold 
value or persistence of effects being noted and where the rea-
son of classification was not indicated (chemicals classified 
in the absence of a classification triggering effect) (Table 1).
Draize eye test method
The historical data from the RCD and NCD were generated 
with albino rabbits according to the OECD Test Guideline 
405 (OECD 2012a). Briefly, a single dose (100 μl volume 
for liquids and solids) of the test material was placed into the 
conjunctiva cul-de-sac of the eye of the animal. Solid chemi-
cals in the LNS database and at least the ones tested after 
2002 in the NCD were rinsed from the eye 1 h after applica-
tion with saline or distilled water when the solids were still 
present (according to the 2002 revision of OECD TG 405, 
even though LNS predates this revision), while solid chemi-
cals in the ECETOC and ZEBET databases were not (these 
chemicals were tested according to OECD TG 405 prior to 
its 2002 revision). Subsequently, the eyes were observed at 
selected time intervals for up to 21 days for signs of ocular 
lesions. For each RCD and NCD chemical, the following 
endpoints driving classification were determined and evalu-
ated: corneal opacity (CO), iritis (IR), conjunctiva chemosis 
(CC), conjunctiva redness (CR), and days to clear. Scores for 
lesions were given from 1 to 2 for IR, from 1 to 3 for CR, 
and from 1 to 4 for CO and CC. A score of 0 was given to a 
tissue when no lesions were observed in that tissue.
UN GHS and EU CLP classification of the RCD and NCD 
chemicals
The UN GHS and EU CLP classification of chemicals 
tested in albino rabbits according to the Draize eye test 
method (OECD 2012a) is primarily based on the severity of 
effects and timing of reversibility of effects. According to 
the UN GHS and EU CLP classification systems, Category 
1 is defined as causing irreversible effects on the eye/seri-
ous damage to the eye and Category 2 as causing revers-
ible effects on the eye/eye irritation. The classification rules 
defined by UN GHS (UN 2013) and EU CLP (EC 2008) 
and the ECHA Guidance on the application of the CLP cri-
teria for classification of studies with more than three ani-
mals (ECHA, 2012; chapter 3.3.2.3.2.2 In vivo data) were 
used to classify all the chemicals (from individual studies) 
included in our analyses. An overview of the classification 
rules is presented in Table 2. First, mean CO, IR, CC, and 
CR scores over the reading times at 24, 48, and 72 h were 
calculated for each animal. Next, the second highest (for 
studies with 3 or 4 animals) or the third highest (for stud-
ies with 5 or 6 animals) of the mean CO, IR, CR, and CC 
Table 2  Classification rules defined by UN GHS (UN 2013) and EU CLP (EC 2008)
COMaj , IRMaj, CRMaj, and CCMaj: correspond to the second highest (for studies with 3 or 4 animals) or the third highest (for studies with 5 or 6 
animals) of the mean CO, IR, CR, and CC scores (of gradings at 24, 48, and 72 h). UN GHS criteria (UN 2013) and the ECHA Guidance on the 
application of the CLP criteria for classification of studies with more than three animals (ECHA, 2012; chapter 3.3.2.3.2.2 In vivo data) were 
applied (i.e. 2 out of 3, 3 out of 4, 3 out of 5, or 4 out of six animals with a mean score above a classification cut-off)
CO corneal opacity, IR iritis, CR conjunctiva redness, CC conjunctiva chemosis
a
 Mean scores are calculated from gradings at 24, 48, and 72 h after instillation of the test material and used to determine the classification of 
the chemical based on COMaj, IRMaj, CRMaj, and CCMaj
b
 All effects have to fully reverse within an observation period of normally 21 days. UN GHS provides the option to distinguish this single haz-
ard category into two optional subcategories (not implemented in EU CLP): “Category 2A” (irritant to eyes) when any of the eye effects in any 
animal is not fully reversible within 7 days of observation (i.e. CO, IR, CR and/or CC > 0 at 7 ≤ day < 21); “Category 2B” (mildly irritant to 
eyes) when all observed eye effects are fully reversible within 7 days of observation (i.e. CO, IR, CR and CC = 0 at day 7 and beyond)
c
 Cat 1 also applies when CO = 4 or other severe reactions (e.g. destruction of cornea, discoloration of the cornea by a dye substance, adhe-
sion, pannus, or interference with the function of the iris or other effects that impair sight) are observed at any time point in any rabbit during 
the observation period, and/or when effects that are not expected to reverse, or have not fully reversed within an observation period of normally 
21 days (persistent effects) are observed (i.e. score > 0 on day 21 on any tissue in any animal)
Endpoint Range scoresa Category 2b Category 1c
Reversible effects on the eye/eye irritation Irreversible effects on the eye/serious damage to eyes
CO 0–4 1 ≤ COMaj < 3; and/or COMaj ≥ 3; and/or
IR 0–2 1 ≤ IRMaj ≤ 1.5; and/or IRMaj > 1.5
CR 0–3 CRMaj ≥ 2; and/or
CC 0–4 CCMaj ≥ 2
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scores (COMaj, IRMaj, CRMaj and CCMaj) were determined 
for each study to examine if the majority of the animals 
(i.e. 2 out of 3, 3 out of 4, 3 out of 5 or 4 out of 6 animals) 
had a mean tissue score less than, equal to or greater than 
the defined threshold value(s) for classification. An UN 
GHS/EU CLP Category 1 (Cat 1) was assigned based on 
COMaj ≥ 3 and/or IRMaj > 1.5 and/or CO = 4 (observed at 
any time point in any rabbit during the observation period, 
before day 21) and/or a persistent effect (score >0 on day 
21 on any tissue in any animal). An UN GHS/EU CLP 
Category 2 (Cat 2) classification was assigned based on 
1 ≤ COMaj < 3 and/or 1 ≤ IRMaj ≤ 1.5 and/or CRMaj ≥ 2 
and/or CCMaj ≥ 2. If none of the criteria for Cat 1 and Cat 2 
defined above were met, the chemical does not require clas-
sification for serious eye damage/eye irritation, and there-
fore, No Category (No Cat) was assigned.
Within-test variability
To assess the within-test variability, the individual rabbit 
data were used. As mentioned above, mean CO, IR, CR, and 
CC values over the reading times at 24, 48, and 72 h were 
calculated for each animal. According to the Draize scale, 
the CO and CC grading can assume values of 0, 1, 2, 3, or 4. 
This means that for the individual rabbits, the mean over the 
reading times at 24, 48, and 72 h can take 13 different val-
ues (from 0 to 4 in steps of 0.33). This rule also applies to 
the other endpoints except that the maximum scores for IR 
and CR are 2 and 3, thus resulting in seven and ten possible 
mean values, respectively. Sometimes, the CO, IR, CR, or 
CC mean scores for the animals, and as a consequence, the 
second (n = 3 or 4) or third (n = 5 or 6) highest mean scores 
(COMaj, IRMaj, CRMaj or CCMaj), deviated from the possible 
values. Therefore, the COMaj, IRMaj, CRMaj and CCMaj val-
ues were assigned to intervals ([0, 0.33[, [0.33, 0.67[, [0.67, 
1[, [1, 1.33[, [1.33, 1.67[, [1.67, 2[, [2, 2.33[, [2.33, 2.67[, 
[2.67, 3[, [3, 3.33[, [3.33, 3.67[, [3.67, 4[, [4]) that were 
represented by the corresponding values of 0, 0.33, 0.67, 
1, 1.33, 1.67, 2, 2.33, 2.67, 3, 3.33, 3.67, 4, respectively. 
The within-test variability of the individual mean tissue 
scores is presented by means of frequency tables (one for 
each tissue), with the individual rabbit mean CO, IR, CR, 
or CC scores of each study/chemical (rows) being presented 
against the study/chemical COMaj, IRMaj, CRMaj or CCMaj 
values (columns), respectively. In this analysis, the chemi-
cals were grouped according to their COMaj, IRMaj, CRMaj or 
CCMaj value for each of the tissues evaluated.
The within-test variability of the individual mean tissue 
scores was also assessed by means of boxplots represent-
ing the minimum, first quartile, median, third quartile, and 
maximum. In this analysis, the chemicals were grouped 
according to their UN GHS/EU CLP classification and 
classification driver, e.g. the rabbits of all chemicals that 
were classified based on persistence only were pooled 
together (De Wever et al. 2012; Barroso et al. 2013).
Resampling probabilities
In order to determine the effect of the within-test variability 
on the accuracy of the Draize eye test (in terms of misclassi-
fication), resampling was performed. The resampling prob-
abilities were estimated based on the same set of individual 
data that were used to assess the within-test variability. First, 
the data set was grouped according to UN GHS/EU CLP 
classification and further subdivided by classification driver. 
In this way, it was assured that the rabbits used in the vari-
ous resamplings always came from studies with chemicals 
classified with the same UN GHS/EU CLP category (i.e. No 
Cat, Cat 2, or Cat 1) and in some cases even only from stud-
ies with chemicals that were classified based on the same 
endpoint. Next, data on 10,000 simulated chemicals were 
generated, i.e. a random sample of three rabbits was drawn 
10,000 times from the data pool without replacement (Rao 
1966). This means that each animal entered a simulated 
chemical only once. Finally, the UN GHS/EU CLP classi-
fication criteria were applied for these simulated chemicals 
and predictive capacity (correct classification) was calcu-
lated by comparing the theoretical classification (resulting 
from the resampling approach) with the observed classifica-
tion. All analyses were performed in R version 3.0.0.
Results
Overview of the compiled data set: distribution according 
to UN GHS/EU CLP classification
Table 1 shows the total number of in vivo Draize eye stud-
ies present in each of the databases used in the present anal-
yses. The RCD (ECETOC, ZEBET, and LNS) contains 344 
studies, of which 70 were excluded from the analyses for 
not fulfilling the quality criteria defined in chapter 2.1. The 
NCD in turn contains 2319 individual studies, of which 459 
were excluded. In total, 274 RCD studies and 1,860 NCD 
studies were used in the present analyses. Table 1 also pre-
sents the distribution of UN GHS/EU CLP categories in the 
RCD and NCD. The proportion of classified chemicals in 
the RCD is 39.8 % (17.2 % Cat 2 and 22.6 % Cat 1), as 
compared to only 17.4 % (10.4 % Cat 2 and 6.9 % Cat 1) 
in the NCD. The RCD in general also contains more Cat 
1 than Cat 2 chemicals, whereas the opposite is observed 
for the NCD (Table 1). The distribution of UN GHS/EU 
CLP categories observed in the NCD is expected to repre-
sent more closely the prevalence of Cat 2 and Cat 1 in the 
chemical world than what is observed in the RCD, since the 
NCD contains all chemicals registered by multiple industry 
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sectors since 1981, while the RCD contains a limited num-
ber of chemicals that were put together in databases mainly 
to support validation studies.
Effects driving UN GHS/EU CLP classification
The proportions of the in vivo studies that led to an UN 
GHS/EU CLP Cat 1 or Cat 2 classification based on a 
specific endpoint or on a combination of endpoints [here 
named classification drivers, as described by De Wever 
et al. (2012) and Barroso et al. (2013)] are presented in 
Tables 3 and 5 for Cat 1 and Cat 2, respectively.
The chemicals classified as Cat 1 in the RCD and NCD 
were subgrouped according to four main classification driv-
ers (Table 3). All chemicals with the second (n = 3 or 4) or 
third (n = 5 or 6) highest animal mean CO score equal to or 
greater than 3 (COMaj ≥ 3) were grouped together. Chemi-
cals classified as Cat 1 based on a CO equal to 4 observed 
any time during the observation period (before day 21) but 
having the second (n = 3 or 4) or third (n = 5 or 6) highest 
animal mean CO score less than 3 (CO = 4, and COMaj < 3) 
were pooled in a second group. The chemicals classified as 
Cat 1 based only on a second (n = 3 or 4) or third (n = 5 or 
6) highest animal mean IR score greater than 1.5 (IRMaj > 1.5 
only) were placed in a third group. These first three groups 
represent classification drivers related to severity of ocu-
lar lesions. Finally, chemicals that did not show sufficiently 
severe ocular lesions (COMaj < 3, IRMaj ≤ 1.5 and CO ≠ 4) 
but that were classified Cat 1 based on persistence of effects 
(Persistence only) were separated and further subdivided into 
those that showed persistence of CO and those that showed 
persistence of CR, CC and/or IR, but not CO (No CO).
The majority of the chemicals classified based on sever-
ity in both the RCD and NCD have COMaj ≥ 3 (RCD: 
32.3 %; NCD: 24.0 %). In the RCD, also a large percentage 
of the chemicals showed CO = 4 (and COMaj < 3) (29.0 %). 
In both the RCD and NCD, Cat 1 classification based on 
IRMaj > 1.5 only was quite rare (<4 %). In total, more Cat 
1 chemicals were classified based on severity in the RCD 
(64.5 %) than in the NCD (34.9 %). On the other hand, the 
proportion of chemicals that were classified Cat 1 based on 
persistence only was 65.1 % in the NCD (52.7 % with CO 
persistence and 12.4 % with only CR, CC and/or IR persis-
tence) and 35.5 % in the RCD (25.8 % with CO persistence 
and 9.7 % with only CR, CC and/or IR persistence). All of 
the 10–12 % Cat 1 chemicals that were classified based on 
persistence of effects other than corneal opacity (“No CO” 
in Table 3) always showed CR and/or CC persistent effects, 
and the grades were generally low (mostly ≤2 and many 
with a grade of 1). Only a few of these chemicals showed IR 
persistent effects (27 %, 6/22). Overall, 61.3 % of the Cat 1 
chemicals from the RCD generated persistent effects in the 
rabbits in comparison with 82.1 % for the NCD. It should, 
however, be pointed out that for 33.8 and 16.3 % of the Cat 
1 chemicals in the RCD and in the NCD, respectively, the 
study was stopped before day 21 and, as such, it is unknown 
if the effect(s) would have persisted until day 21. For two 
data sources of the RCD (ECETOC and ZEBET), individ-
ual data were available until day 21. For the third RCD data 
source (LNS), individual data were available only until day 
14, together with comments indicating if effects were per-
sisting at day 21. In the NCD, individual animal data were 
only available for the mean scores of days 1–3, again with 
only summary information being provided regarding the 
persistence of effects at day 21 (only the maximum score at 
the end of the observation period for the whole study is pro-
vided). In ECETOC and ZEBET, if an effect was persistent 
at day 21, this was mainly observed on the cornea (44.4 % 
of animals) followed by conjunctiva redness (34.7 %), con-
junctiva chemosis (20.2 %) (39 % with persistent conjunc-
tiva redness and/or chemosis) and iris (16.2 %) (Table 4). 
The severity of CO (grade 1, 2, 3, or 4) and IR (grade 1 or 
2) on day 21 is more or less equally distributed over the 
grades, whereas for the conjunctiva effects, lower grades 
were observed more frequently.
The chemicals classified as Cat 2 in the RCD and NCD 
were themselves subgrouped according to three main classifi-
cation drivers (Table 5). All chemicals with the second (n = 3 
Table 3  Proportion of 
Cat 1 chemicals that were 
classified according to specific 
classification drivers
CO corneal opacity, IR iritis, 
RCD Reference Chemicals 
Databases, NCD European New 
Chemicals Database
a
 second (n = 3 or 4) or third 
(n = 5 or 6) highest mean score
b
 Observed any time during 
the observation period (before 
day 21)
Effects Severity % (n) Persistence only  % (n)
COMaj a ≥ 3 CO = 4b  
(and COMaj a < 3)
IRMaj a > 1.5 only CO No CO
RCD (n = 62) 32.3 (20) 29.0 (18) 3.2 (2) 25.8 (16) 9.7 (6)
 Reversible 3.2 (2) 1.6 (1) 0.0 (0)
 Persistent 11.3 (7) 14.5 (9) 0.0 (0)
 Unknown 17.7 (11) 12.9 (8) 3.2 (2)
NCD (n = 129) 24.0 (31) 7.0 (9) 3.9 (5) 52.7 (68) 12.4 (16)
 Reversible 0.8 (1) 0.8 (1) 0.0 (0)
 Persistent 8.5 (11) 6.2 (8) 2.3 (3)
 Unknown 14.7 (19) 0.0 (0) 1.6 (2)
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or 4) or third (n = 5 or 6) highest animal mean CO score 
equal to or greater than 1 but less than 3 (1 ≤ COMaj < 3) 
were grouped together. The chemicals having the largest of 
the second (n = 3 or 4) or third (n = 5 or 6) highest animal 
mean CR and CC scores equal to or greater than 2 but having 
the second (n = 3 or 4) or third (n = 5 or 6) highest animal 
mean CO score less than 1 (CRMaj/CCMaj ≥ 2 and COMaj < 1) 
were pooled into another group. Finally, the chemicals clas-
sified as Cat 2 based only on a second (n = 3 or 4) or third 
(n = 5 or 6) highest animal mean IR score equal to or greater 
than 1 but less than or equal to 1.5 (1 ≤ IRMaj ≤ 1.5 only) 
were placed together in the last group.
The majority of the Cat 2 chemicals showed sufficient 
CO effects to generate a Cat 2 classification per se (RCD: 
74.5 %; NCD: 54.1 %), but these were often accompanied 
by conjunctiva effects that would also trigger a Cat 2 clas-
sification (86 and 63 % of the RCD and NCD Cat 2 chemi-
cals classified based on CO effects, respectively, represent-
ing 63.9 and 34.0 % of all Cat 2 chemicals in the RCD and 
NCD, respectively) (Table 5). Importantly, also a consider-
able amount of Cat 2 chemicals were classified based on 
conjunctiva effects without showing classifiable CO effects 
(RCD: 25.5 %; NCD: 43.3 %). Altogether, an impressive 
89.4 and 77.3 % of the Cat 2 chemicals in the RCD and 
NCD, respectively, showed sufficient conjunctiva effects to 
generate a Cat 2 classification per se. Of the two conjunc-
tiva effects, CR is the predominant one in all databases, with 
CC rarely appearing without parallel CR effects (<10 %). A 
very small proportion (2.6 %) of the chemicals in the NCD 
was classified Cat 2 because of iritis only. The effects on the 
iris seem therefore to be of lesser importance for classifica-
tion of chemicals under the UN GHS/EU CLP system.
Another important observation in the RCD data set 
is that high CO scores (≥3) were able to reverse to 0 by 
day 21 or earlier. Of the 66 animals with CO = 3 scored 
any time during the observation period (before day 21), 33 
(50 %) recovered to CO = 0 by day 21 or earlier. CO > 0 at 
day 21 was observed for 15 (22.7 %) animals, and no con-
clusion could be drawn for 18 (27.3 %) animals because 
the study was stopped before day 21. Of note, even 8.8 % 
(5/57) of the animals with extreme CO scores (CO = 4) 
noted any time during the observation period (before day 
21) recovered to CO = 0 by day 21 or earlier, whereas CO 
persistence at day 21 was observed in 29.8 % (17/57) of 
these animals. As expected, the study was stopped before 
day 21 for a large proportion of these animals (61.4 %, 
35/57), due to animal welfare concerns, and therefore, it 
remains unknown if full recovery could occur in any of 
these cases. Interestingly, mean CO scores over the read-
ing times at 24, 48, and 72 h ≥3, reversed to 0 by day 21 or 
earlier in as high as 19.3 % (11/57) of the animals.
Within-test variability of tissue scores
Mean tissue scores (calculated over the reading times at 24, 
48, and 72 h for an individual animal) were available for all 
Table 4  Distribution of the individual tissue scores on day 21 by 
endpoint for the chemicals from the RCD (ECETOC and ZEBET) 
that resulted in a persistent effect in at least one animal (n = 124 ani-
mals) a
CO corneal opacity, IR iritis, CR conjunctiva redness, CC conjunctiva 
chemosis, NA not applicable
a
 Individual data for day 21 were only available for ECETOC and 
ZEBET databases. For 2 out of 124 animals, the study stopped before 
day 21 and the tissue score was not reversed to 0; these two animals 
were therefore not included in this table
Endpoint Tissue score (proportion of animals)
0 1 2 3 4
CO 54.0 13.7 12.1 8.1 10.5
IR 82.3 8.1 8.1 NA NA
CR 63.7 24.2 8.9 1.6 NA
CC 78.2 11.3 7.3 1.6 0.0
Table 5  Proportion of 
Cat 2 chemicals that were 
classified according to specific 
classification drivers
CO corneal opacity, IR iritis, 
CR conjunctiva redness, 
CC conjunctiva chemosis, 
RCD Reference Chemicals 
Databases, NCD European New 
Chemicals Database, NA not 
applicable
a
 second (n = 3 or 4) or third 
(n = 5 or 6) highest mean score
b
 The largest of the second 
(n = 3 or 4) or third (n = 5 or 
6) highest mean CR and CC 
scores
Effects Severity % (n)
1 ≤ COMaj a < 3 CRMaj/CCMaj b ≥ 2  
(and COMaj a < 1)
1 ≤ IRMaj a ≤ 1.5 only
RCD (n = 47) 74.5 (35) 25.5 (12) 0.0 (0)
 CRMaj + CCMaj 36.2 (17) 6.4 (3) NA
 CRMaj only 21.3 (10) 17.0 (8) NA
 CCMaj only 6.4 (3) 2.1 (1) NA
 COMaj only 10.6 (5) NA NA
NCD (n = 194) 54.1 (105) 43.3 (84) 2.6 (5)
 CRMaj + CCMaj 14.9 (29) 7.2 (14) NA
 CRMaj only 18.6 (36) 34.0 (66) NA
 CCMaj only 0.5 (1) 2.1 (4) NA
 COMaj only 20.1 (39) NA NA
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rabbits tested with the RCD and NCD chemicals included 
in the analyses presented in this study. These data were 
used to assess the within-test variability of each individual 
tissue scoring (Tables 6, 7, 8, 9).   
According to the Draize eye test scoring system, the 
mean CO calculated over the reading times at 24, 48, and 
72 h of an individual animal can take 13 possible values, 
which are shown as individual rows in Table 6. Conse-
quently, the COMaj of each individual study/chemical can 
only assume one of those 13 values (see chapter 2.4 in the 
“Materials and Methods”), which are shown as individual 
columns in Table 6. A chemical tested in three animals 
with mean animal CO scores of 0, 0.33, 0.33 (second high-
est value = 0.33) places the chemical in the column corre-
sponding to COMaj equal to 0.33, with the individual animal 
mean scores added in the respective rows (i.e. 2 counted in 
the row corresponding to 0.33, and 1 counted in the row 
corresponding to 0). In total, 25 chemicals (83 animals) of 
Table 6  Within-test variability of the mean CO scores calculated over the reading times at 24, 48, and 72 h. Proportion of animals within each 
COMaj group
Animal COMaj: 2nd (n=3 or 4) or 3rd (n=5 or 6) highest mean CO scores
mean CO 0.00 0.33 0.67 1.00 1.33 1.67 2.00 2.33 2.67 3.00 3.33 3.67 4.00
score NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD
4 . . . . . . . . . . . . . 1.4 . 9.1 . . . . 16.7 . 33.3 22.2 85.7 66.7
3.67 . . . . . . . . . . . . . . . . . . . 3.6 16.7 . 33.3 44.4 4.8 .
3.33 . . . . . . . . . . . 3.6 . 2.8 . . . . 5.6 3.6 33.3 . . 11.1 . .
3 . . . . . . . . . 2.4 6.1 0.0 4.9 6.9 . 9.1 . 18.8 83.3 67.9 16.7 . . 11.1 . .
2.67 0.0 . . 1.2 . . 0.6 . . 2.4 3.0 3.6 1.2 0.0 . 18.2 77.8 62.5 0.0 10.7 0.0 . 33.3 11.1 0.0 .
2.33 . . . . 0.5 . . . 3.7 4.8 0.0 3.6 0.0 6.9 . 36.4 . 6.3 . 7.1 . . . . . .
2 0.1 0.2 . 2.4 1.1 8.0 5.4 1.2 7.4 9.5 15.2 14.3 79.0 61.1 . 9.1 22.2 6.3 5.6 7.1 16.7 . . . . 16.7
1.67 0.1 0.2 . 1.2 1.1 8.0 5.4 7.4 13.0 9.5 57.6 50.0 2.5 9.7 . . . . . . . . . . . .
1.33 0.1 . 3.4 1.2 3.2 8.0 2.5 4.9 48.1 45.2 3.0 21.4 2.5 4.2 . 9.1 . 6.3 . . . . . . 4.8 .
1 0.5 0.4 8.2 7.2 19.0 8.0 69.5 74.1 16.7 11.9 9.1 . 3.7 2.8 . 9.1 . . 5.6 . . . . . . .
0.67 1.0 0.6 9.5 13.3 50.3 48.0 5.7 3.7 5.6 7.1 3.0 . 1.2 2.8 . . . . . . . . . . . 16.7
0.33 1.3 2.0 55.1 50.6 8.5 16.0 2.9 3.7 . 7.1 . . 1.2 . . . . . . . . . . . . .
0 97.0 96.7 23.8 22.9 16.4 4.0 7.9 4.9 5.6 . 3.0 3.6 3.7 1.4 . . . . . . . . . . 4.8 .
Tot animals 4602 543 147 83 189 25 315 81 54 42 33 28 81 72 0 22 9 16 18 28 6 . 3 9 21 6
Above box 38 4 17 11 47 8 0 0 0 1 2 1 4 8 0 4 0 3 - - - - - - - -
Within box 4564 539 130 72 142 17 263 71 48 35 29 26 72 61 0 18 9 13 16 21 5 0 2 8 19 4
Below box - - - - - - 52 10 6 6 2 1 5 3 0 0 0 0 2 7 1 0 1 1 2 2
Tot chemicals 1534 146 49 25 63 8 105 25 18 10 11 8 27 18 0 6 3 4 6 8 2 0 1 3 7 2
Proportions that fall in the light-grey area (No Cat range) correspond to animals with mean CO < 1 that were tested with chemicals with 
COMaj  < 1; Proportions that fall in the grey area (Cat 2 range) correspond to animals with 1 ≤ mean CO < 3 that were tested with chemicals 
with 1 ≤ COMaj < 3; Proportions that fall in the dark-grey area (Cat 1 range) correspond to animals with mean CO ≥ 3 that were tested with 
chemicals with COMaj ≥ 3; Proportions in bold (diagonal) correspond to animals with mean CO scores equal to the COMaj of the chemicals 
tested in those animals
CO corneal opacity, NCD European New Chemicals Database, RCD Reference Chemicals Databases
Table 7  Within-test variability of the mean IR scores calculated over the reading times at 24, 48, and 72 h. Proportion of animals within each 
IRMaj group
Animal IRMaj: 2nd (n=3 or 4) or 3rd (n=5 or 6) highest mean IR scores
mean IR 0.00 0.33 0.67 1.00 1.33 1.67 2.00
score NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD
2 . . . . 1.4 . 1.8 4.8 . 6.3 . 20.0 81.5 84.6
1.67 . . 0.4 4.5 0.7 4.2 . 4.0 33.3 6.3 . 60.0 7.4 7.7
1.33 . . . 3.0 . 1.4 0.7 4.8 50.0 62.5 . 20.0 . 7.7
1 0.3 0.9 6.3 12.1 18.4 22.5 83.5 76.2 16.7 12.5 . . 7.4 .
0.67 0.5 0.8 10.8 6.1 54.6 49.3 5.9 6.3 . 6.3 . . . .
0.33 2.0 3.2 62.5 53.0 12.1 15.5 4.4 2.4 . . . . . .
0 97.2 95.1 20.0 21.2 12.8 7.0 3.7 1.6 . 6.3 . . 3.7 .
Tot animals 4791 653 240 66 141 71 273 126 6 16 0 10 27 13
Above box 15 6 16 13 29 20 5 11 2 2 - - - -
Within box 4777 647 224 53 112 51 230 102 4 12 0 8 24 12
Below box - - - - - - 38 13 0 2 0 2 3 1
Tot chemicals 1597 178 80 20 47 20 91 35 2 4 0 3 9 3
Proportions that fall in the light-grey area (No Cat range) correspond to animals with mean IR < 1 that were tested with chemicals with 
IRMaj  < 1; Proportions that fall in the grey area (Cat 2 range) correspond to animals with 1 ≤ mean IR ≤ 1.5 that were tested with chemicals 
with 1 ≤ IRMaj ≤ 1.5; Proportions that fall in the dark-grey area (Cat 1 range) correspond to animals with mean IR > 1.5 that were tested with 
chemicals with IRMaj > 1.5; Proportions in bold (diagonal) correspond to animals with mean CO scores equal to the IRMaj of the chemicals tested 
in those animals
IR iritis, NCD European New Chemicals Database, RCD Reference Chemicals Databases
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the RCD had COMaj score equal to 0.33, with individual 
mean CO scores ranging from 0 (22.9 % of the animals) to 
2.67 (1.2 % of the animals).
The within-test variability for the mean CO, IR, CR, and 
CC scores was very similar for the RCD and NCD (Tables 6, 
7, 8, 9). These figures only reflect the variability observed 
over the first 3 days for each tissue effect separately and 
do not take into account the timing of reversibility. Over-
all, only a small proportion of the animals from chemicals 
with COMaj, IRMaj, CRMaj or CCMaj scores below the Cat 2 
classification threshold (COMaj < 1; IRMaj < 1; CRMaj < 2; 
CCMaj < 2) had individual mean tissue scores above the Cat 
Table 8  Within-test variability of the mean CR scores calculated over the reading times at 24, 48, and 72 h. Proportion of animals within each 
CRMaj group
Animal CRMaj: 2nd (n=3 or 4) or 3rd (n=5 or 6) highest mean CR scores
mean CR 0.00 0.33 0.67 1.00 1.33 1.67 2.00 2.33 2.67 3.00
score NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD
3 . . . . . . . 1.0 0.4 . . 1.7 1.9 8.0 3.5 9.3 21.3 30.8 84.0 86.1
2.67 . . . . . . 0.3 1.0 . . 0.7 5.1 2.9 6.3 7.0 16.0 60.0 61.5 7.3 12.7
2.33 . . . . . . 0.2 1.0 0.4 . 1.7 5.1 8.0 8.0 59.6 49.3 5.3 3.8 2.7 1.3
2 0.1 . 0.3 . 0.3 . 2.8 . 6.7 4.3 14.7 15.3 69.3 63.4 17.5 13.3 8.0 3.8 4.0 0.0
1.67 0.2 . 0.9 . 1.7 2.3 4.3 9.3 12.0 13.0 57.7 50.8 8.5 7.1 3.5 5.3 . . . .
1.33 . . 0.6 0.7 3.0 1.2 8.0 19.6 61.8 65.2 10.7 15.3 2.9 3.6 5.3 2.7 . . 1.3 .
1 2.1 0.4 4.4 4.4 10.6 16.3 64.4 50.5 9.7 13.0 7.3 6.8 4.3 3.6 . 4.0 5.3 . 0.7 .
0.67 1.8 2.9 7.8 9.6 61.5 59.3 10.1 8.2 4.5 2.2 3.7 . 0.5 . 1.8 . . . . .
0.33 7.0 8.8 71.6 67.6 16.9 12.8 8.0 8.2 4.1 2.2 2.7 . 1.1 . 1.8 . . . . .
0 88.9 87.9 14.3 17.6 6.0 8.1 2.0 1.0 0.4 . 1.0 . 0.5 . . . . . . .
Tot animals 1605 239 1395 136 603 86 651 97 267 46 300 59 375 112 57 75 75 26 150 79
Above box 1 0 4 0 2 0 21 3 20 2 51 16 - - - - - - - -
Within box 1604 239 1391 136 601 86 630 94 247 44 249 43 308 96 50 66 71 26 147 79
Below box - - - - - - - - - - - - 67 16 7 9 4 0 3 0
Tot chemicals 535 66 465 36 201 22 217 26 89 14 100 17 125 28 19 21 25 8 50 25
Proportions that fall in the light-grey area (No Cat range) correspond to animals with mean CR < 2 that were tested with chemicals with 
CRMaj  < 2; Proportions that fall in the grey area (Cat 2 range) correspond to animals with mean CR ≥ 2 that were tested with chemicals with 
CRMaj ≥ 2; Proportions in bold (diagonal) correspond to animals with mean CR scores equal to the CRMaj of the chemicals tested in those ani-
mals
CR conjunctiva redness, NCD European New Chemicals Database, RCD Reference Chemicals Databases
Table 9  Within-test variability of the mean CC scores calculated over the reading times at 24, 48, and 72 h. Proportion of animals within each 
CCMaj group
Animal CCMaj: 2nd (n=3 or 4) or 3rd (n=5 or 6) highest mean CC scores 
mean CC 0.00 0.33 0.67 1.00 1.33 1.67 2.00 2.33 2.67 3.00 3.33 3.67 4.00 
score NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD NCD RCD 
4 . . . . . . . . . . . . . 1.2 1.6 . 4.2 . 0.0 3.7 16.7 16.7 33.3 44.4 79.2 80.0 
3.67 . . . . . . . . . . 1.4 1.5 . . . . 2.1 7.1 2.2 11.1 11.1 16.7 33.3 22.2 4.2 8.0 
3.33 . . . . . . . . . . . . . 1.2 . . 4.2 . . 7.4 50.0 50.0 . 11.1 8.3 4.0 
3 . . . . 0.4 . 0.6 . 0.5 2.0 2.8 . 2.4 3.7 3.2 6.1 12.5 21.4 75.6 48.1 5.6 16.7 16.7 22.2 4.2 4.0 
2.67 . . . . 0.4 2.6 0.6 . 1.0 . 2.8 3.1 4.0 4.9 7.9 24.2 52.1 42.9 6.7 11.1 5.6 . . . . . 
2.33 . . . . 0.4 . 0.9 . 1.0 11.8 2.8 6.2 8.7 13.4 61.9 51.5 6.3 10.7 . 11.1 . . . . . 4.0 
2 . 0.2 0.2 . 0.9 . 3.7 . 7.5 5.9 18.1 20.0 65.1 58.5 12.7 6.1 4.2 7.1 8.9 0.0 . . 16.7 . . . 
1.67 0.0 0.5 0.3 0.9 0.9 2.6 3.1 2.4 10.0 9.8 45.8 44.6 7.9 8.5 3.2 6.1 4.2 7.1 2.2 7.4 . . . . . . 
1.33 0.1 . 1.7 1.7 4.9 . 9.7 14.6 58.2 49.0 11.1 10.8 6.3 7.3 3.2 3.0 8.3 3.6 4.4 . 11.1 . . . . . 
1 0.6 0.5 5.4 5.2 13.3 10.5 60.4 58.5 10.4 17.6 4.2 7.7 3.2 1.2 1.6 3.0 . . . . . . . . 4.2 . 
0.67 0.8 1.4 6.3 10.3 54.7 65.8 6.6 12.2 4.0 0.0 5.6 1.5 . . 1.6 . 2.1 . . . . . . . . . 
0.33 5.5 4.4 68.7 64.7 15.6 15.8 9.7 12.2 5.5 3.9 2.8 3.1 1.6 . 1.6 . . . . . . . . . . . 
0 92.9 93.1 17.2 17.2 8.4 2.6 4.8 0.0 2.0 0.0 2.8 1.5 0.8 . 1.6 . . . . . . . . . . . 
Tot animals 3432 434 867 116 225 38 351 41 201 51 72 65 126 82 63 33 48 28 45 27 18 6 6 9 24 25 
Above box 0 1 2 0 5 1 20 0 20 10 20 20 - - - - - - - - - - - - - - 
Within box 3432 433 865 116 220 37 331 41 181 41 52 45 101 68 55 29 41 25 42 25 16 6 6 9 23 25 
Below box - - - - - - - - - - - - 25 14 8 4 7 3 3 2 2 0 0 0 1 0 
Tot chemicals 1144 116 289 32 75 12 117 12 67 15 24 18 42 22 21 8 16 8 15 8 6 2 2 2 8 8 
Proportions that fall in the light-grey area (No Cat range) correspond to animals with mean CC < 2 that were tested with chemicals with 
CCMaj  < 2; Proportions that fall in the grey area (Cat 2 range) correspond to animals with mean CC ≥ 2 that were tested with chemicals with 
CCMaj ≥ 2; Proportions in bold (diagonal) correspond to animals with mean CC scores equal to the CCMaj of the chemicals tested in those ani-
mals
CC conjunctiva chemosis, NCD European New Chemicals Database, RCD Reference Chemicals Databases
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2 classification threshold for the respective tissue: 3.5 % for 
CO (23/651), 4.9 % for IR (39/790), 3.2 % for CR (21/663) 
and 4.3 % for CC (32/745) of the animals in the RCD and 
2.1 % for CO (102/4,938), 1.2 % for IR (60/5,172), 2.1 % for 
CR (99/4,821), and 1.3 % for CC (67/5,148) of the animals in 
the NCD (all animals counted above the light-grey boxes in 
Tables 6, 7, 8, and 9). A higher variability was observed for 
chemicals with COMaj or IRMaj between the Cat 2 and the Cat 
1 classification thresholds (1 ≤ COMaj < 3; 1 ≤ IRMaj ≤ 1.5) 
or with CRMaj or CCMaj above the Cat 2 classification thresh-
old (CRMaj ≥ 2; CCMaj ≥ 2). For 14.2 % (37/261), 19.7 % 
(28/142), 8.6 % (25/292), and 11 % (23/210) of the animals 
from the RCD and 14.4 % (71/492), 16.1 % (45/279), 12.3 % 
(81/657), and 13.9 % (46/330) of the animals from the NCD 
the mean tissue scores were outside the region delimited by 
the Cat 2 and Cat 1 classification thresholds for CO (mean 
CO < 1 or mean CO ≥ 3) and IR (mean IR < 1 or mean 
IR > 1.5) (all animals counted above and below the grey boxes 
in Table 6 and 7), and below the Cat 2 classification threshold 
for CR and CC (mean CR < 2; mean CC < 2) (all animals 
counted below the grey boxes in Tables 8 and 9), respectively. 
Moreover, for the chemicals with COMaj between the Cat 2 
and the Cat 1 classification thresholds (1 ≤ COMaj < 3), 7.7 % 
(20/261) of the animals from the RCD had mean CO scores 
below the Cat 2 classification threshold (mean CO < 1) and 
6.5 % (17/261) had mean CO scores above the Cat 1 clas-
sification threshold (mean CO ≥ 3). In the NCD, on the other 
hand, 13.2 % (65/492) of the animals had mean CO scores 
below the Cat 2 classification threshold (mean CO < 1) and 
only 1.2 % (6/492) of the animals had mean CO scores above 
the Cat 1 classification threshold (mean CO ≥ 3). Simi-
larly, for the chemicals with IRMaj between the Cat 2 and the 
Cat 1 classification thresholds (1 ≤ IRMaj ≤ 1.5), 10.6 % 
(15/142) of the animals from the RCD had mean IR scores 
below the Cat 2 classification threshold (mean IR < 1) and 
9.2 % (13/142) had mean IR scores above the Cat 1 classifi-
cation threshold (mean IR > 1.5), while in the NCD, 13.6 % 
(38/279) of the animals had mean IR scores below the Cat 2 
classification threshold (mean IR < 1), and only 2.5 % (7/279) 
of the animals had mean IR scores above the Cat 1 classifi-
cation threshold (mean IR > 1.5). Finally, for the chemicals 
with COMaj or IRMaj above the Cat 1 classification thresh-
old (COMaj ≥ 3; IRMaj > 1.5), a substantial 23.3 % (10/43) 
or 13.0 % (3/23) (RCD) and 12.5 % (6/48) or 11.1 % (3/27) 
(NCD) of the animals had mean CO or IR scores, respec-
tively, below the Cat 1 classification threshold (all animals 
counted below the dark-grey box in Tables 6 and 7).
Within-test variability of mean tissue scores 
per classification driver
The within-test variability of the mean tissue scores was 
further evaluated by grouping the data of the different 
studies available in the RCD and NCD according to the 
UN GHS/EU CLP classification of the tested chemicals 
and their classification driver as described above (De Wever 
et al. 2012; Barroso et al. 2013). These data are presented 
in boxplots that illustrate the distribution of the animals 
mean CO score (Fig. 1a), mean IR score (Fig. 1b), mean 
CR score (Fig. 2a), and mean CC score (Fig. 2b), per clas-
sification driver.
Chemicals not classified for serious eye damage/eye 
irritation (No Cat) in both the RCD and NCD have in 
the majority of the animals mean CO scores and mean 
IR scores equal to 0 (Fig. 1). The majority of these ani-
mals also have mean CC scores less than or equal to 0.33 
(Fig. 2b). Of note, the mean CR scores are equal to or 
greater than 0.33 but less than 2 for the majority of these 
animals in both databases (Fig. 2a).
In both the RCD and NCD, the majority of the animals 
tested with chemicals that were classified Cat 2 based on 
1 ≤ COMaj < 3 have mean CO scores between the Cat 2 
and the Cat 1 classification thresholds (Fig. 1a). However, 
the animal mean CO scores are generally lower in the NCD 
than in the RCD. The mean IR scores in the NCD and 
RCD, on the other hand, are less than 1 in the majority of 
the animals tested with this group of chemicals (Fig. 1b). 
Furthermore, in both the NCD and RCD, the mean CR 
scores of the Cat 2 chemicals that were classified based on 
1 ≤ COMaj < 3 are equal to or greater than 2 in the major-
ity of the animals (75.0 % (93/124) in the RCD and 59.4 % 
(187/315) in the NCD), but with a larger proportion being 
below this score in the NCD than in the RCD (Fig. 2a). The 
same was observed for the animal mean CC scores in the 
RCD database. For the NCD, however, the mean CC scores 
are less than 2 in the majority of the animals. In the NCD 
and RCD, the majority of the animals tested with chemicals 
that were classified Cat 2 based on conjunctiva effects, but 
without enough corneal involvement to generate a classifi-
cation, have mean CR scores that are above the Cat 2 clas-
sification threshold (Fig. 2a) but have mean CO, IR, and 
CC scores that are below the Cat 2 classification threshold 
(Figs. 1a, 2a, b). This means that the great majority of these 
chemicals were classified based on CRMaj only (see also 
Table 5).
In both the RCD and NCD, the majority of the animals 
tested with chemicals that were classified Cat 1 based 
on COMaj ≥ 3 have mean CO scores equal to or greater 
than 3 (Fig. 1a). The mean CO scores of the animals 
tested with chemicals that were classified Cat 1 based on 
a CO = 4 (and COMaj < 3), IRMaj > 1.5 only or Persis-
tence only are generally above the CO Cat 2 classifica-
tion threshold and mostly below the Cat 1 classification 
threshold (1 ≤ mean CO < 3) for both databases (Fig. 1a). 
It is important to note, however, that for the NCD, about 
25 % (50/198) of the animals tested with chemicals that 
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were classified Cat 1 based on persistence only have both 
mean CO and mean IR scores less than 1 (Fig. 1). The 
mean CR scores of the animals tested with classified 
chemicals cover in general the same range independently 
of the classification (Cat 2 or Cat 1) or the classification 
driver (Fig. 2a), which means that practically no distinc-
tion can be made between Cat 2 and Cat 1 chemicals on 
the basis of CR. On the other hand, the mean CC scores 
of especially the Cat 1 chemicals that were classified 
based on COMaj (COMaj ≥ 3), CO = 4 (and COMaj < 3), or 
IRMaj (IRMaj > 1.5) are generally higher than the mean CC 
scores of the Cat 2 chemicals (Fig. 2b).
Resampling probabilities
The influence of within-test variability on the UN GHS/EU 
CLP chemical classification was further explored using a 
statistical resampling technique without replacement. Only 
studies with individual data on at least three rabbits were 
taken into account. In the resampling approach used in 
this study, simulated chemicals were created by randomly 
grouping together three animals that may have been tested 
with different chemicals (for details see chapter 2.5 in the 
“Materials and Methods”). For this reason, the different 
studies available in the RCD and NCD were first pooled 
Fig. 1  Boxplots presenting the distribution of individual animal 
mean CO (a) and mean IR (b) scores calculated over the reading 
times at 24, 48, and 72 h by classification driver. NCD: European 
New Chemicals Database, RCD: Reference Chemicals Databases, 
No Cat: not classified, Cat 2—1 ≤ COMaj < 3: classified based on 
majority of mean CO scores equal to or greater than 1 but less than 
3, Cat 2—CRMaj/CCMaj ≥ 2 (and COMaj < 1): classified based on 
majority of mean CR and/or CC scores equal to or greater than 2 but 
with majority of mean CO scores less than 1, Cat 2—1 ≤ IRMaj ≤ 1.5 
only: classified based on majority of mean IR scores equal to or 
greater than 1 but less than or equal to 1.5, Cat 1—COMaj ≥ 3: clas-
sified based on majority of mean CO scores equal to or greater than 
3, Cat 1—CO = 4 (and COMaj < 3): classified based on CO = 4 but 
with majority of mean CO scores less than 3, Cat 1—IRMaj > 1.5 
only: classified based on majority of mean IR scores greater than 1.5, 
Cat 1—Persistence only: classified based on persistence only. The 
whiskers correspond with the smallest and largest observation that 
fall within a distance of 1.5 times the length of the box (Interquartile 
Range, IQR) from the lower (bottom side of the box) and upper quar-
tile (upper side of the box), respectively
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according to the UN GHS/EU CLP classification of the 
tested chemicals and also further subdivided according to 
their classification driver as described above (De Wever 
et al. 2012; Barroso et al. 2013). Separate resampling 
analyses were then performed on each of these individual 
data pools. The individual simulated chemicals obtained 
from the different resamplings were therefore built either 
(1) on animals coming from studies with chemicals clas-
sified with the same UN GHS/EU CLP category (i.e. No 
Cat, Cat 2, or Cat 1) independently of the classification 
driver (taking all classification drivers together) or (2) on 
animals coming from studies with chemicals classified 
with the same UN GHS/EU CLP category and having the 
same endpoint driving such classification. For the chemi-
cals of the NCD, only the individual animal mean tissue 
scores calculated over the reading times at 24, 48, and 72 h 
are available. Information on persistence of effects is only 
available in the form of comments, often not specifying in 
which tissues and in how many animals the persistence of 
effects was observed. It was therefore not possible to esti-
mate the resampling probabilities for the chemicals that 
were classified based only on CO = 4 (observed any time 
during the observation period, before day 21) or persis-
tence of a tissue effect.
Fig. 2  Boxplots presenting the distribution of individual animal 
mean CR (a) and mean CC (b) scores calculated over the reading 
times at 24, 48, and 72 h by classification driver. NCD: European 
New Chemicals Database, RCD: Reference Chemicals Databases, 
No Cat: not classified, Cat 2—1 ≤ COMaj < 3: classified based on 
majority of mean CO scores equal to or greater than 1 but less than 
3, Cat 2—CRMaj/CCMaj ≥ 2 (and COMaj < 1): classified based on 
majority of mean CR and/or CC scores equal to or greater than 2 but 
with majority of mean CO scores less than 1, Cat 2—1 ≤ IRMaj ≤ 1.5 
only: classified based on majority of mean IR scores equal to or 
greater than 1 but less than or equal to 1.5, Cat 1—COMaj ≥ 3: clas-
sified based on majority of mean CO scores equal to or greater than 
3, Cat 1—CO = 4 (and COMaj < 3): classified based on CO = 4 but 
with majority of mean CO scores less than 3, Cat 1—IRMaj > 1.5 
only: classified based on majority of mean IR scores greater than 1.5, 
Cat 1—Persistence only: classified based on persistence only. The 
whiskers correspond with the smallest and largest observation that 
fall within a distance of 1.5 times the length of the box (Interquartile 
Range, IQR) from the lower (bottom side of the box) and upper quar-
tile (upper side of the box), respectively
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In the RCD, 165 chemicals were not classified for seri-
ous eye damage/eye irritation according to the UN GHS/
EU CLP classification criteria (No Cat). This group con-
sisted of 606 individual animals (Table 10). A random 
sample of three rabbits was drawn 10,000 times from this 
data pool of 606 rabbits, and the UN GHS/EU CLP clas-
sification criteria were applied. As can be seen in Table 10, 
almost all of the simulated chemicals were also identified 
as No Cat (99.9 %). Only 0.1 % (8 chemicals) were classi-
fied Cat 2, and none of the simulated chemicals were clas-
sified Cat 1. Identical results were obtained for the NCD 
data pool. Thus, resampling from the RCD and NCD data 
pools of the non-classified compounds rarely resulted in 
misclassifications, which may be explained by the fact that 
the great majority of the individual animal mean CO, IR, 
CR, and CC scores observed for the No Cat chemicals in 
both databases are below the Cat 2 classification cut-offs 
(Figs. 1, 2).
The total number of animals available for estimating 
the resampling probabilities for the UN GHS/EU CLP Cat 
2 was 162 for the RCD and 582 for the NCD (Table 10). 
Only a small proportion of the simulated chemicals from 
the RCD was under-predicted (3.9 %) and very few were 
over-predicted (0.6 %). For the NCD, however, the under-
prediction rate was substantially higher (11.7 %) but again 
only 0.1 % of the simulated chemicals were predicted as 
Cat 1. Separate resamplings were also performed for each 
Cat 2 classification driver. For the Cat 2 chemicals that 
were classified based on COMaj, the majority of the ani-
mals in both the RCD and NCD have mean CO scores 
between the Cat 2 and the Cat 1 classification thresholds 
(1 ≤ mean CO < 3) (Fig. 1a). Moreover, many of the ani-
mals in the 1 ≤ COMaj < 3 RCD and NCD data pools also 
showed mean CR scores equal to or greater than 2 (Fig. 2a; 
Table 5). This resulted in a low resampling misclassifi-
cation error for these data pools with more than 94 % of 
Table 10  Resampling probabilities of 10,000 theoretical chemicals according to UN GHS/EU CLP criteria
Proportions in bold represent agreement between the predicted classification and the true classification
RCD Reference Chemicals Databases, NCD European New Chemicals Database, CO corneal opacity, CR conjunctiva redness, CC conjunctiva 
chemosis, IR iritis, NA not applicable
a
 None of the chemicals in this group was classified based on the driver 1 ≤ IRMaj ≤ 1.5 only
b
 second (n = 3 or 4) or third (n = 5 or 6) highest mean score
c
 The largest of the second (n = 3 or 4) or third (n = 5 or 6) highest mean CR and CC scores
d
 Observed any time during the observation period (before day 21)
e
 Individual animal data only accessible for the mean scores of days 1–3. Information on persistence of effects is only available in the form of 
comments, often not specifying in which tissues and in how many animals the persistence of effects was observed. Consequently, it was not pos-
sible to estimate the resampling probabilities for the chemicals that were classified based only on CO = 4 (observed any time during the obser-
vation period, before day 21) or persistence of a tissue effect. The resampling probabilities reported for the classification drivers COMaj ≥ 3 and 
IRMaj > 1.5 should therefore not be considered as representative of the overall resampling probabilities for chemicals classified as Cat 1 in the 
NCD
True class Database Endpoint Sample size Predicted class
No Cat Cat 2 Cat 1
No Cat RCD 606 99.9 0.1 0.0
NCD 4,611 99.9 0.1 0.0
Cat 2 RCD Alla 162 3.9 95.5 0.6
1 ≤ COMaj b < 3 124 2.3 97.2 0.6
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 38 6.0 94.1 NA
NCD All 582 11.7 88.2 0.1
1 ≤ COMaj b < 3 315 5.0 94.8 0.2
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 252 9.7 90.3 NA
1 ≤ IRMaj b ≤ 1.5 only 15 7.6 92.4 0.0
Cat 1 RCD All 187 0.0 10.8 89.2
COMaj b ≥ 3 43 0.0 1.7 98.3
CO = 4d (and COMaj b < 3) 61 0.0 13.0 87.0
IRMaj b > 1.5 only 7 0.0 14.2 85.8
Persistence only 76 0.1 13.5 86.4
NCD COMaj b ≥ 3 + IRMaj b > 1.5 onlye 63 0.0 7.2 92.8
COMaj b ≥ 3 48 0.0 1.9 98.1
IRMaj b > 1.5 only 15 0.0 8.2 91.8
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the simulated chemicals being correctly predicted as Cat 
2 eye irritants (Table 10). A higher misclassification error 
was observed for the chemicals classified as Cat 2 based 
on conjunctiva effects and without enough corneal involve-
ment to generate a classification (CRMaj/CCMaj ≥ 2 and 
COMaj < 1), with under-prediction rates of 6.0 and of 9.7 % 
being obtained for the RCD and NCD, respectively. The 
majority of these chemicals were classified based on CRMaj 
(Table 5: only 2.1 % in both the RCD and NCD were clas-
sified based on CCMaj only), but some of the individual ani-
mal mean CR scores were still below the Cat 2 classifica-
tion threshold of 2, with the median of all values being at 
(NCD) or very close to (RCD) this cut-off score (Fig. 2a). 
More importantly, the great majority of the individual ani-
mal’ mean CC scores for these chemicals were below this 
threshold (Fig. 2b). In fact, altogether 17 and 13 % of the 
animals from chemicals in the NCD and RCD, respectively, 
that were classified as Cat 2 based on conjunctiva effects, 
but without enough corneal involvement to generate a clas-
sification, had mean CR and CC scores <2. This indeed 
accounts for the higher variability observed for these chem-
icals. Only the NCD contains chemicals classified as Cat 2 
based on iritis only (1 ≤ IRMaj ≤ 1.5 only). These showed 
an under-classification rate of 7.6 %, which is in between 
the 5.0 % obtained for COMaj and the 9.7 % obtained for 
CRMaj/CCMaj. Overall, the under-classification errors for 
the Cat 2 chemicals were always higher than the over-clas-
sification errors, with the latter being almost neglectable.
As explained above, resampling from the whole Cat 1 
data pool could only be performed for the chemicals from 
the RCD. When all classification drivers were taken into 
account in the RCD, resampling resulted in an under-predic-
tion rate as Cat 2 of 10.8 % and practically no under-predic-
tion as NC (Table 10). Under-predictions as NC were actu-
ally only observed for a small proportion of the simulated 
chemicals that were classified based on persistence only 
(0.1 % or 13/10,000) (Table 10). The classification drivers 
that most contributed to the overall under-prediction rate 
observed for all Cat 1 RCD chemicals were persistence of 
effects and CO = 4, each showing individually an under-
prediction rate of about 13 %. The chemicals classified as 
Cat 1 based only on persistence of effects have mean CO 
scores of similar grade as the Cat 2 chemicals that were 
classified based on COMaj ≥ 1 (Fig. 1a). However, in the 
NCD, more than 25 % of the animals from this group of 
Cat 1 chemicals have mean CO scores <1 (Fig. 1a), which 
strongly suggests that the under-prediction rate for this 
subgroup is even higher than what is observed in the RCD 
(>13.5 %). The mean CO scores for the chemicals clas-
sified as Cat 1 based on CO = 4, on the other hand, were 
clearly higher than those for the chemicals classified as 
Cat 2 based on COMaj ≥ 1, but the majority were still well 
within the Cat 2 scores, i.e. below the Cat 1 classification 
threshold (Fig. 1a). This may still explain the high vari-
ability observed for this classification driver. Interestingly, 
the mean CO scores for the chemicals classified as Cat 1 
based on CO = 4 were markedly higher for the RCD than 
for the NCD (Fig. 1a), suggesting that the under-prediction 
rate of the NCD is probably also higher for these chemi-
cals than that of the RCD (>13.0 %). In fact, the misclas-
sification rates were always higher in the NCD than in the 
RCD for both Cat 1 and Cat 2 chemicals as well as for all 
individual classification drivers. It is therefore expected that 
the overall variability for Cat 1 in the NCD (if the chemi-
cals classified based on CO = 4 only and on persistence of 
effects only could also be considered) is at least as high as 
the one obtained with the RCD and probably even higher 
(>10.8 %). A considerable under-prediction error of 14.2 % 
(RCD) and 8.2 % (NCD) was obtained for the chemicals 
classified as Cat 1 based on IRMaj > 1.5 only. Finally, chemi-
cals that were classified Cat 1 based on COMaj ≥ 3 showed 
a low under-prediction rate in both the RCD (1.7 %) and 
NCD (1.9 %) (Table 10). This result is expected consid-
ering that the COMaj ≥ 3 data pool encloses several Cat 1 
classification drivers. All chemicals in this group meet the 
COMaj ≥ 3 criterion but some will also meet one or several 
of the other Cat 1 criteria as well, in particular persistence 
of effects and/or CO = 4. For example, 53.8 % (23/43) of 
the animals in the RCD COMaj ≥ 3 data pool also have a 
CO = 4 observed at least at one time point during the obser-
vation period. Moreover, the majority of the animals in this 
group have mean CO scores ≥3 (87.5 % in the NCD and 
76.7 % in the RCD). This will of course decrease the vari-
ability of this data pool, since the probability of meeting at 
least one of the Cat 1 criteria in the resampled chemicals is 
quite high. Accordingly, of all the Cat 1 classification driv-
ers, COMaj ≥ 3 was the one showing the lowest variability.
Resampling probabilities in function of physical state
It was further explored if the physical state of the chemical 
had an impact on the within-test variability. Therefore, the 
same resampling analyses as described in the previous sec-
tion were performed on the liquids and solids separately. 
These results are presented in Tables 11 and 12. Data on 
the physical state could not be retrieved for 20 chemicals 
from the ZEBET database (RCD) and for one chemical of 
the NCD, and therefore, these chemicals were not included 
in these analyses. The separate resampling for the liquids 
and solids of the NCD resulted in a slightly higher overall 
under-prediction of Cat 2 chemicals for the solids (12.7 %) 
than for the liquids (9.8 %). The misclassification error for 
the 1 ≤ COMaj < 3 classification driver was also higher for 
solids (5.6 %) than for liquids (3.5 %), but the opposite was 
observed for the CRMaj/CCMaj ≥ 2 (without COMaj ≥ 1) 
classification driver, with under-prediction rates of 11.9 
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and 9.2 % being obtained for the Cat 2 liquids and solids, 
respectively. The exact same trends were observed for the 
Cat 2 chemicals from the RCD, but the difference between 
liquids and solids for the CRMaj/CCMaj ≥ 2 (without 
COMaj ≥ 1) classification driver was substantially higher, 
with the liquids showing a much larger under-prediction 
rate (12.0 %) than the solids (1.3 %). Another important 
difference between the liquids and solids of the RCD was 
observed for the Cat 1 chemicals classified based only on 
persistence of effects, with the under-prediction rate as Cat 
2 obtained for the liquids being almost 12 % higher than for 
the solids. The solids showed an already high under-predic-
tion rate of 10.4 %, but the under-prediction rate obtained 
with the liquids was as large as 22.2 %. Not surprisingly, 
7 out of the 10 liquids from this data pool showed persis-
tence of effects in only one of the tested animals, with four 
of these being 6 animal studies (two times CO persistence 
and two times CR persistence only). As expected, this led 
to a very large variability upon resampling of the data, with 
even a few under-predictions as No Cat being obtained 
(0.1 %). In fact, persistence only for the RCD liquids was 
the only classification driver that showed under-prediction 
of Cat 1 chemicals as No Cat. No important difference was 
observed between liquids and solids for the remaining Cat 
1 classification drivers that could be resampled separately 
for both physical states, i.e. COMaj ≥ 3 and CO = 4.
Discussion
For more than two decades, scientists have been trying to 
replace the regulatory Draize eye test by in vitro methods, 
but so far only partial replacement has been achieved. In 
order to better understand the reasons for this apparent 
Table 11  Resampling probabilities of 10,000 theoretical chemicals according to UN GHS/EU CLP criteria—liquids
Proportions in bold represent agreement between the predicted classification and the true classification
RCD Reference Chemicals Databases, NCD European New Chemicals Database, CO corneal opacity, CR conjunctiva redness, CC conjunctiva 
chemosis, IR iritis, NA not applicable
a
 None of the chemicals in this group was classified based on the driver 1 ≤ IRMaj ≤ 1.5 only
b
 second (n = 3 or 4) or third (n = 5 or 6) highest mean score
c
 The largest of the second (n = 3 or 4) or third (n = 5 or 6) highest mean CR and CC scores
d
 Observed any time during the observation period (before day 21)
e
 Sample size is too small to perform a separate resampling analysis for this driver
f
 Individual animal data only accessible for the mean scores of days 1–3. Information on persistence of effects is only available in the form of 
comments, often not specifying in which tissues and in how many animals the persistence of effects was observed. Consequently, it was not pos-
sible to estimate the resampling probabilities for the chemicals that were classified based only on CO = 4 (observed any time during the obser-
vation period, before day 21) or persistence of a tissue effect. The resampling probabilities reported for the classification drivers COMaj ≥ 3 and 
IRMaj > 1.5 should therefore not be considered as representative of the overall resampling probabilities for chemicals classified as Cat 1 in the 
NCD
True class Database Endpoint Sample size Predicted class
No Cat Cat 2 Cat 1
No Cat RCD 399 99.9 0.1 0.0
NCD 1,002 99.9 0.1 0.0
Cat 2 RCD Alla 123 3.2 96.2 0.6
1 ≤ COMaj b < 3 103 2.1 97.5 0.5
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 20 12.0 88.0 NA
NCD Alla 156 9.8 90.2 0.0
1 ≤ COMaj b < 3 99 3.5 96.5 0.0
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 57 11.9 88.1 NA
Cat 1 RCD All 94 0.0 15.3 84.7
COMaj b ≥ 3 25 0.0 1.4 98.6
CO = 4d (and COMaj b < 3) 22 0.0 12.1 87.9
IRMaj b > 1.5 only 4e NA NA NA
Persistence only 43 0.1 22.2 77.7
NCD COMaj b ≥ 3 + IRMaj b > 1.5 onlyf 9 1.1 1.3 97.7
COMaj b ≥ 3 6 0.0 0.0 100.0
IRMaj b > 1.5 only 3e NA NA NA
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lack of success, historical in vivo rabbit eye irritation data 
from three Reference Chemicals Databases (RCD), namely 
ECETOC, ZEBET and LNS, and from the European New 
Chemicals Database (NCD) were evaluated.
The analyses presented in this paper show that about 
83 % of the chemicals that were registered in the NCD 
with valid data for the purpose of these analyses were not 
classified (No Cat). Furthermore, 10 % were classified as 
UN GHS/EU CLP Cat 2 (reversible effects on the eye/irri-
tant to eyes) and 7 % as UN GHS/EU CLP Cat 1 (irrevers-
ible effects on the eye/serious eye damage). This preva-
lence is expected to be closer to the reality than what is 
observed in the RCD, which contains a higher number of 
classified chemicals, since the NCD contains all chemicals 
registered by multiple industry sectors since 1981, while 
the RCD contains a limited number of chemicals that were 
put together in databases mainly to support validation 
studies.
Differences in the endpoints driving classification were 
also observed between the RCD and NCD. For example, 
65 % of the Cat 1 chemicals in the NCD were classified 
based on persistence of effects only, whereas this was 35 % 
for the RCD. Importantly, chemicals that were classified 
Cat 1 based only on persistence of effects in both the RCD 
and NCD have individual animal mean CO scores that are 
mostly below 3 (in 74/76 rabbits) and mean IR scores that 
are mostly below 1.5 (in 72/76 rabbits), i.e. below the CO 
and IR Cat 1 classification thresholds (Fig. 1). In fact, in 
the NCD, more than 25 % of the animals from this group 
of Cat 1 chemicals actually have mean CO scores below 1, 
while most of them in both the NCD and RCD have mean 
IR scores below 1, i.e. the CO and IR No Cat score ranges. 
Table 12  Resampling probabilities of 10,000 theoretical chemicals according to UN GHS/EU CLP criteria—solids
Proportions in bold represent agreement between the predicted classification and the true classification
RCD Reference Chemicals Databases, NCD European New Chemicals Database, CO corneal opacity, CR conjunctiva redness, CC conjunctiva 
chemosis, IR iritis, NA not applicable
a
 None of the chemicals in this group was classified based on the driver 1 ≤ IRMaj ≤ 1.5 only
b
 second (n = 3 or 4) or third (n = 5 or 6) highest mean score
c
 The largest of the second (n = 3 or 4) or third (n = 5 or 6) highest mean CR and CC scores
d
 Observed any time during the observation period (before day 21)
e
 Sample size is too small to perform a separate resampling analysis for this driver
f
 Individual animal data only accessible for the mean scores of days 1–3. Information on persistence of effects is only available in the form of 
comments, often not specifying in which tissues and in how many animals the persistence of effects was observed. Consequently, it was not pos-
sible to estimate the resampling probabilities for the chemicals that were classified based only on CO = 4 (observed any time during the obser-
vation period, before day 21) or persistence of a tissue effect. The resampling probabilities reported for the classification drivers COMaj ≥ 3 and 
IRMaj > 1.5 should therefore not be considered as representative of the overall resampling probabilities for chemicals classified as Cat 1 in the 
NCD
True class Database Endpoint Sample size Predicted class
No Cat Cat 2 Cat 1
No Cat RCD 152 100.0 0.0 0.00
NCD 3,606 99.9 0.1 0.00
Cat 2 RCD Alla 33 5.0 95.0 0.0
1 ≤ COMaj b < 3 15 2.8 97.2 0.0
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 18 1.3 98.7 NA
NCD All 426 12.7 87.2 0.0
1 ≤ COMaj b < 3 216 5.6 94.3 0.1
CRMaj/CCMaj c ≥ 2 (and COMaj b < 1) 195 9.2 90.8 NA
1 ≤ IRMaj b ≤ 1.5 only 15 7.6 92.4 0.0
Cat 1 RCD All 78 0.0 8.2 91.9
COMaj b ≥ 3 18 0.0 1.1 98.7
CO = 4d (and COMaj b < 3) 39 0.0 12.7 87.3
IRMaj b > 1.5 only 3e NA NA NA
Persistence only 18 0.0 10.4 89.6
NCD COMaj b ≥ 3 + IRMaj b > 1.5 onlyf 54 0.0 6.7 93.3
COMaj b ≥ 3 42 0.0 3.1 96.9
IRMaj b > 1.5 only 12 0.0 4.7 95.3
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This demonstrates that low tissue scores in the beginning 
of a study (days 1–3) are not predictive of the absence of 
persistent effects. It could be speculated that these chemi-
cals induce eye irritation by different modes of action than 
those that induce immediate severe effects (e.g. through 
delayed effects or persistence of low-level effects). For this 
reason and because persistence of effects seems to play 
such an important role in the classification of a chemical as 
Cat 1 by the in vivo method, it may be necessary to have in 
vitro test methods capable of directly detecting persistence 
of effects. Certainly, it is known that the under-predictions 
for Cat 1 chemicals obtained with organotypic methods like 
BCOP and ICE, which were developed to detect immedi-
ate severe effects, are more likely for chemicals classified 
in vivo based only on persistence of effects than for those 
classified based on severity (ICCVAM 2006a, b, 2007). 
Two other organotypic methods, the Ex-Vivo Eye Irritation 
Test (EVEIT) based on isolated rabbit corneas (Spöler et al. 
2007; Frentz et al. 2008) and the Porcine Corneal Ocular 
Reversibility Assay (PorCORA) based on isolated porcine 
corneas (Piehl et al. 2010, 2011), have been proposed to 
directly address reversibility/persistence of effects, but 
neither has yet undergone a formal validation study. Both 
these methods are based on the direct monitoring of the 
healing process in exposed excised corneas kept in culture 
over several days. This type of methods may be needed for 
the correct identification of Cat 1 chemicals and may sig-
nificantly contribute in a testing strategy to the full replace-
ment of the in vivo Draize eye test method.
Of note, a substantial proportion of the Cat 1 chemicals 
is currently being classified based only on persistence of 
conjunctiva effects (6.5 % (4/62) in the RCD and 9.3 % 
(12/129) in the NCD). More importantly, the majority of 
these chemicals are classified as Cat 1 based only on a CR 
and/or CC score of 1 at day 21 (all 4 chemicals from the 
RCD and 8 of the 12 from the NCD). In fact, the sever-
ity of CO (grade 1, 2, 3, or 4) and IR (grade 1 or 2) at day 
21 for Cat 1 chemicals showing persistence of effects in 
at least one animal is more or less equally distributed over 
the grades, whereas for CR and CC, lower grades were 
observed more frequently, with the majority being scores 
equal to 1 (Table 4). This suggests that conjunctiva effects 
behave differently than corneal or iris effects, in that con-
junctiva effects are mostly reversible by nature indepen-
dently of the chemical tested, while iritis and especially 
corneal opacity are not. What is more, CR and CC are the 
only in vivo endpoints that consistently show scores greater 
than 0 for No Cat chemicals (Figs. 1, 2). CR in particular 
actually shows mean scores equal to or greater than 1 in 
25.6 % (155/606) and 23.6 % (1,088/4,611) of the animals 
that were tested with No Cat chemicals in the RCD and in 
the NCD, respectively. Some conjunctiva redness may even 
be present in non-treated animals. It is therefore highly 
questionable to treat CR and CC in a similar way as CO 
and IR when it comes to classify chemicals as Cat 1 based 
on persistence of effects at day 21. Based on the data pre-
sented here, we believe that chemicals should not be clas-
sified as Cat 1 based on CR and/or CC scores at day 21 
greater than 0 but less than the Cat 2 classification threshold 
(i.e. 0 < CR/CC < 2), in the absence of any other Cat 1-trig-
gering effects. Indeed, CR and/or CC scores of less than 2 
at day 21 should be considered as fully reversed conjunc-
tiva effects and, for animal welfare reasons, animal stud-
ies should be stopped when CO and IR have fully reversed 
to scores equal to 0, and CR and CC have reached scores 
of less than 2. This is already the case with the U.S. EPA 
classification system, which considers CR and CC scores 
of less than 2 as fully cleared (U.S. EPA 1998, 2011). Con-
siderations should therefore be given to a revision of UN 
GHS and EU CLP in the same direction.
It is also currently accepted and expressed in multi-
ple regulations (EC 2008; OECD 2012a; UN 2013) that 
extreme CO scores should be irreversible by nature. How-
ever, in several cases of animals scored with a CO = 4 
any time during the observation period (in at least 9 % of 
the animals), these extreme opacities were able to reverse 
to 0 by day 21 or even earlier (e.g. in the RCD, 9 animals 
scored with a CO = 4 reversed to CO = 0 by days 21 (2 
animals), 11, 10, 7 (4 animals), and even 3). Considering 
the subjective scoring of the effects observed in the in vivo 
Draize eye test, it is debatable if such chemicals should be 
classified Cat 1 in the absence of any other Cat 1-triggering 
effects, i.e. with COMaj < 3, with IRMaj ≤ 1.5, and with-
out persistence of effects at day 21. Again, according to the 
U.S. EPA classification system, chemicals showing CO = 4 
that reverses to 0 by day 21 or earlier are not classified as 
U.S. EPA Cat I if CO and IR revert to 0 and CR and CC 
revert to less than 2 by day 21 in all tested animals (U.S. 
EPA 1998, 2011). In fact, under UN GHS and EU CLP, Cat 
1 is also associated with “irreversible effects on the eye”, 
being defined as “the production of tissue damage in the 
eye,… which is not fully reversible within 21 days of appli-
cation”, while Cat 2 is associated with “reversible effects 
on the eye”, being defined as “the production of changes 
in the eye …, which are fully reversible within 21 days of 
application”. So, according to these definitions, such chem-
icals should indeed be classified as Cat 2, but currently a 
CO = 4 is taking precedence over the fact that the observed 
injury might be reversible by day 21. It is our opinion that 
UN GHS and EU CLP should be revised to clarify this situ-
ation, and it is our recommendation that if a study was con-
tinued after a CO = 4 was noted and it was shown that the 
observed effect was fully reversible within 21 days, such 
CO = 4 should not trigger a Cat 1 classification. Moreover, 
seeing that CO = 4 could be a highly subjective scoring 
that is not always linked to persistence of corneal opacity at 
718 Arch Toxicol (2014) 88:701–723
1 3
day 21, it would probably be more correct to only terminate 
studies where CO = 4 is observed before day 21, without 
investigating the reversibility of the effect and accepting 
a Cat 1 classification, if such effects are observed in the 
majority of the animals tested, i.e. in 2 out of 3, 3 out of 4, 
3 out of 5, or 4 out of 6 animals. This approach seems rea-
sonable seeing that it would be identical to what is already 
used for the other severity based criteria COMaj and IRMaj.
In our analyses, iritis was found to rarely drive the clas-
sification of chemicals in vivo (both Cat 1 and Cat 2) on 
its own (<4 % of the chemicals from both NCD and RCD) 
(Tables 3, 5). In fact, when the iris shows scores above the 
classification cut-offs, these are almost every time accom-
panied by corneal opacity scores also above the classifi-
cation cut-offs. Specifically, 95.7 % (44/46) of the chemi-
cals in the RCD and 89.2 % (83/93) of the chemicals in 
the NCD that have 1 ≤ IRMaj ≤ 1.5 (Cat 2 range) also 
have COMaj ≥ 1, and 88.9 % (8/9) of the chemicals in the 
RCD and 55.6 % (5/9) of the chemicals in the NCD that 
have IRMaj > 1.5 (Cat 1 range) also have COMaj ≥ 3 and/
or CO = 4. As such, effects on the iris are of lesser impor-
tance for classification of chemicals under the UN GHS/
EU CLP classification systems. Therefore, it seems logical 
to deprioritise the development of new in vitro methods to 
predict iritis as well as the use of this endpoint as reference 
in the development of in vitro testing strategies.
Our analyses also show that the two most important end-
points that drive Cat 2 classification in both the RCD and 
NCD are conjunctiva redness and corneal opacity. These 
two endpoints together account for the classification of 
more than 95 % of the Cat 2 chemicals in both the RCD 
and NCD, which again demonstrates the lack of weight of 
iritis, but also of conjunctiva chemosis, in the identification 
of Cat 2 chemicals with the current in vivo Draize eye test 
method. Altogether, 80.9 % of the Cat 2 chemicals in the 
RCD and 74.7 % of those in the NCD are classified based 
on CRMaj ≥ 2 (versus 51.1 % (RCD), and 24.7 % (NCD) 
based on CCMaj ≥ 2), while 74.5 % of the Cat 2 chemi-
cals in the RCD and 54.1 % of those in the NCD are classi-
fied based on COMaj ≥ 1. Interestingly, conjunctiva redness 
appears to be twice as important as corneal opacity for the 
classification of Cat 2 chemicals on their own since 23.4 % 
and 41.2 % of the Cat 2 chemicals in the RCD and NCD, 
respectively, are classified based on CRMaj ≥ 2 without 
enough corneal opacity to generate a classification, while 
only 10.6 % and 20.1 % of the Cat 2 chemicals in the RCD 
and NCD, respectively, are classified based on COMaj ≥ 1 
without enough conjunctiva redness to generate a clas-
sification. This indicates that there will also be a need for 
in vitro methods that can identify conjunctiva effects, and 
especially conjunctiva redness, to fully replace the in vivo 
Draize eye test if the animal data continue to be interpreted 
as currently expressed in UN GHS and EU CLP and the 
classifications obtained thereafter continue being used as 
reference in the evaluation/validation of alternative meth-
ods. The Hen’s Egg Test–Chorioallantoic Membrane (HET-
CAM) (Luepke 1985; de Silva et al. 1992; Gilleron et al. 
1996; Spielmann et al. 1996) and similar methods like 
the Chorioallantoic Membrane Vascular Assay (CAMVA) 
(Bagley et al. 1994) have been proposed to provide infor-
mation on conjunctiva effects in vivo due to the similar-
ity of the CAM to the conjunctiva. Both HET-CAM and 
CAMVA underwent multiple international validation stud-
ies (Bagley et al. 1992b, 1999b; Spielmann et al. 1993, 
1996, 1997; Brantom et al. 1997; Ohno et al. 1999; Hagino 
et al. 1999). More recently, HET-CAM was also formally 
validated by the Interagency Coordinating Committee on 
the Validation of Alternative Methods (ICCVAM) for the 
UN GHS classification system, but it was not considered 
useful at that time to be used for regulatory purposes for 
the evaluation of the serious eye damage/eye irritation 
potential of chemicals, due to the lack of sufficient data for 
Cat 2 chemicals (ICCVAM 2010). Considering the present 
findings, it might be useful to reconsider the usefulness of 
HET-CAM/CAMVA for inclusion in an in vitro eye irrita-
tion testing strategy and evaluate if the additional data gen-
erated since 2009 and/or any modifications to its protocol 
and/or prediction model can be useful for that purpose. It is 
worth mentioning that ICCVAM recommended in particu-
lar that additional data be collected on eye irritants (Cat 2) 
to more adequately characterise the usefulness of the HET-
CAM. Test methods using reconstructed human tissues 
(RhT) modelling the corneal epithelium, like the EpiOcu-
lar™ Eye Irritation Test (EIT) (Kaluzhny et al. 2011; Pfan-
nenbecker et al. 2013) or the SkinEthic™ Human Corneal 
Epithelium (HCE) test (Van Goethem et al. 2006; Cotovio 
et al. 2007, 2010; Alépée et al. 2013), may also be relevant 
for assessing conjunctiva epithelial responses using cyto-
toxicity as an endpoint (OECD 2010). An EURL ECVAM/
Cosmetics Europe prospective validation study on EpiO-
cular™ EIT and SkinEthic™ HCE to evaluate their useful-
ness and limitations for discriminating non-classified mate-
rials versus eye irritants/chemicals inducing serious eye 
damage (Cat 2/Cat 1) is currently ongoing (Freeman et al. 
2010). Considering the small prevalence of eye irritants and 
chemicals inducing serious eye damage (Table 1), these 
methods could be very important for the identification of 
chemicals not requiring classification in a non-animal test-
ing strategy.
The variability of the responses observed between rab-
bits from historical data normally used as reference in 
validation studies is also recognised as a challenging fac-
tor for the success of such studies (Scott et al. 2010) and 
may ultimately hinder the acceptance of in vitro methods. 
Statistical resampling of available historical in vivo Draize 
eye test data was therefore performed to further evaluate 
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the test method’s within-test variability. Our analyses show 
that about 12 % of the NCD chemicals classified as Cat 
2 by the in vivo Draize eye test method and at least 11 % 
of those classified as Cat 1 could in fact be equally iden-
tified as No Cat and as Cat 2, respectively, simply due to 
the inherent within-test variability of this reference method. 
Indeed, the resampling analyses show that the within-test 
variability of the Draize eye test is quite high for the Cat 
2 subgroup that was classified based on CRMaj/CCMaj ≥ 2 
(without COMaj ≥ 1), with under-classification rates as No 
Cat of 6 % (RCD) and 10 % (NCD), and for the Cat 1 sub-
groups that were classified based on CO = 4 only or per-
sistence of effects only, with under-classification rates as 
Cat 2 of about 13 % in the RCD. The under-prediction rate 
for the Cat 1 subgroup that was classified based on persis-
tence of effects only increased to 22 % when only liquids 
were considered. These three classification drivers largely 
contribute to the observed overall under-prediction prob-
ability of Cat 2 chemicals as No Cat of 4 % (RCD) and 
12 % (NCD) and to an overall under-prediction probability 
of Cat 1 chemicals as Cat 2 of at least 11 %. A similar anal-
ysis performed on data of 723 rabbits tested in 181 stud-
ies found under-classification probabilities ranging from 
4.30 to 13.24 %, with the estimated under-classification 
rate also being higher for chemicals classified based on per-
sistence only (Haseman et al. 2005). The under-prediction 
probabilities for the chemicals classified as Cat 2 based 
on 1 ≤ COMaj < 3 and for the chemicals classified as Cat 
1 based on COMaj ≥ 3 were generally smaller than those 
obtained for the other classification drivers, ranging from 1 
to 6 %, depending on the database, the classification driver 
and the physical state of the chemical. This indicates that 
corneal opacity is the most consistent tissue effect observed 
in the Draize eye test and probably also the easiest one 
(least subjective) to score. Not only is corneal opacity the 
endpoint showing lower variability, it is also one of those 
bearing most weight in the classification of chemicals in 
vivo. It is therefore not surprising that most of the in vitro 
methods that have been developed to date address this spe-
cific endpoint, which seems an appropriate strategy to fol-
low. Finally, as opposed to classified chemicals, the within-
test variability for No Cat chemicals was very low; indeed, 
the resampling probability to consistently identify these 
chemicals as No Cat is more than 99 % in both RCD and 
NCD. The No Cat chemicals rarely induce corneal opac-
ity or iritis, and often also no conjunctiva chemosis. The 
only effect that was observed somewhat more frequently 
for these chemicals in the RCD and NCD was some con-
junctiva redness, as already mentioned above, which some-
how disputes the systematic use of this endpoint to classify 
chemicals as Cat 2 using a cut-off score of 2.
It is important to note that the current analyses only 
took into account the within-test variability of the Draize 
eye test method. Weil and Scala (1971) and Cormier et al. 
(1996) studied the variability of responses of nine sub-
stances tested in up to 24 laboratories to address both the 
within- and the between-laboratory variability of the test 
method. The authors showed that the Draize eye test can 
produce quite variable results among laboratories as well 
as within certain laboratories. Certain materials were rated 
as the most irritant tested by some laboratories and, contra-
riwise, as the least irritant by others. The authors suggested 
that the primary reason for the observed extreme varia-
tion between laboratories is in the reading of reactions. 
Unconscious bias or definite tendencies to over- or under-
read reactions or misinterpret the meaning of descriptive 
terms may have accounted for that. In addition, variation in 
interpretation and performance of the procedures was also 
reported as a component for the observed between-labora-
tory variability (Weil and Scala 1971). Marzulli and Rug-
gles (1973) also studied the between-laboratory variability 
of seven materials tested in ten laboratories and confirmed 
the findings from Weil and Scala. Although the authors sug-
gest that laboratories were able in most cases to distinguish 
chemicals inducing serious eye damage/eye irritants from 
non-irritants, statistically significant differences were found 
between collaborators with regard to the tissue readings. 
Thus, if the within- and between-laboratory variability of 
the Draize eye test were to be added to the within-test vari-
ability reported here, it is expected that the overall variabil-
ity of the in vivo method would even increase. For all the 
reasons above, the in vivo under-prediction rates reported 
in this study should be taken into account when evaluating 
alternative methods/strategies to replace the animal test.
Lovell (1996) performed a principal component analysis 
on Draize eye tissue scores obtained 24, 48, and 72 h after 
instillation of a test substance into the rabbit eye for fifty-
five chemicals from the ECETOC database and found that 
the first component, which was highly correlated with the 
maximum individual weighted scores (used to calculate the 
modified maximum average score, MMAS), could already 
explain 76 % of the variability. He concluded that there was 
only limited evidence for differential responses of different 
tissues. This was not confirmed in our study, the main rea-
son being that Lovell focused only on the in vivo scores 
obtained in the first 3 days of the study, while we consid-
ered the full in vivo data necessary to classify according 
to UN GHS/EU CLP decision criteria. Weighed Draize 
scores, like (M)MAS, are irrelevant for regulatory purposes 
as they omit important information like the persistence/
reversibility of effects. Indeed, chemicals with intermediate 
(M)MAS can either correspond to a Cat 1 or a Cat 2 clas-
sification, while chemicals with high (M)MAS are not nec-
essarily classified as Cat 1. Our analyses indicate that under 
current UN GHS/EU CLP classification rules, the (M)MAS 
should not be used as benchmark for the evaluation of in 
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vitro test data. Instead, the focus should be on the classifi-
cation drivers described in this paper.
Conclusions
In vitro methods partially replacing the in vivo Draize eye 
test for the classification of chemicals inducing serious eye 
damage according to UN GHS (Cat 1) are accepted by the 
OECD since 2009 (BCOP TG 437, ICE TG 438) (OECD 
2013a, b) and 2012 (FL TG 460) (OECD 2012b). In addi-
tion, the BCOP and ICE test methods are also accepted 
since 2013 to identify chemicals that do not require clas-
sification under UN GHS (and consequently also under EU 
CLP) (No Cat) (OECD 2013a, b). Finally, the CM (Hartung 
et al. 2010) and the STE (Takahashi et al. 2008, 2009; 
Sakaguchi et al. 2011) have been endorsed as scientifically 
valid for their limited applicability domains (ESAC 2009; 
ICCVAM 2013), and are currently in the process of regula-
tory adoption by the OECD for the identification of chemi-
cals inducing serious eye damage (Cat 1) as well as chemi-
cals not requiring a classification for serious eye damage/
eye irritation (No Cat). Further development and/or evalu-
ation of alternative methods are, however, still required to 
fill the gaps identified in this paper, i.e. persistence/revers-
ibility of effects and identification of Cat 2. Considering the 
importance of conjunctiva effects for the classification of 
Cat 2 chemicals (43 % in the NCD and 26 % in the RCD) 
and of persistence of corneal effects for the classification 
of Cat 1 chemicals (53 % in the NCD and 26 % in the 
RCD), focus and efforts may still have to be given to fur-
ther development and evaluation/validation of alternative 
methods/strategies capable of correctly identifying these 
effects. Several other test methods, e.g. the EpiOcular™ 
EIT (Kaluzhny et al. 2011; Pfannenbecker et al. 2013), the 
SkinEthic™ HCE (Van Goethem et al. 2006; Cotovio et al. 
2007, 2010; Alépée et al. 2013), the Ocular Irritection® 
assay, the PorCORA (Piehl et al. 2010, 2011) or the EVEIT 
(Spöler et al. 2007; Frentz et al. 2008), are currently under-
going validation or are in an advanced status of develop-
ment/optimisation and should soon be accepted for use in a 
regulatory environment. With all these methods becoming 
available, it should now be possible to explore the devel-
opment of highly predictive testing strategies capable of 
fully replacing the animal test. For example, considering 
currently available data, it is likely that test methods such 
as BCOP, ICE, HET-CAM, STE, and RhT-based assays 
like EpiOcular™ EIT or SkinEthic™ HCE, although not 
directly addressing conjunctiva effects (apart maybe from 
HET-CAM), may be able to correctly predict the irritation 
potential of chemicals classified in vivo based only on con-
junctiva effects, when used to discriminate non-classified 
(No Cat) from all classified (Cat 2 + Cat 1) chemicals. 
Priority should therefore be given in the near future to the 
development, optimisation and/or validation of in vitro test 
methods capable of discriminating reversible from irrevers-
ible effects.
In order to develop adequate, stand-alone strategies for 
the assessment of serious eye damage/eye irritation with 
alternative methods, it is important to understand which 
endpoints drive UN GHS/EU CLP classification in the in 
vivo reference method. The endpoint that drives classifica-
tion is also an important factor that needs to be considered 
when selecting representative candidate chemicals for the 
development, validation, and regulatory acceptance of in 
vitro alternatives. It is important not only to select refer-
ence chemicals covering the essential drivers of irritation as 
described in this paper, i.e. severe corneal lesions, persis-
tence of corneal effects in the absence of severe lesions, and 
conjunctiva effects, but also only those having high-quality 
in vivo data, resulting in less questionable and more repro-
ducible classifications (De Wever et al. 2012; Barroso et al. 
2013). At the same time, the UN GHS and EU CLP deci-
sion criteria to classify chemicals based on Draize eye test 
data should be critically reviewed. The resampling analyses 
presented here show that the Draize eye test is prone to high 
misclassification errors. Importantly, these misclassifica-
tion errors are unidirectional towards lower classifications, 
which demonstrates that the way the Draize eye test data 
are interpreted is very conservative and may over-predict 
the true irritation potential of chemicals; indeed, compara-
tive studies between rabbit and man have shown that the 
Draize eye test is likely to overestimate the effects in man 
(Roggeband et al. 2000). The following decision criteria, in 
particular, should therefore be reconsidered: (1) the biolog-
ical relevance of a threshold of 2 for classifying chemicals 
as Cat 2 based on CR should be reassessed considering that 
a significant proportion of No Cat chemicals show mean 
CR scores equal to or greater than 1 and that some CR may 
even be present in non-treated animals; (2) CR and/or CC 
scores of less than 2 at day 21 should be considered as fully 
reversed conjunctiva effects and should therefore not drive 
a Cat 1 classification in the absence of any other Cat 1 trig-
gering effects; (3) CO = 4 that fully reverse within 21 days 
should not trigger a Cat 1 classification in the absence of 
any other Cat 1 triggering effects; and (4) studies where 
CO = 4 is observed should only be terminated before day 
21, without investigating the reversibility of the effect and 
accepting a Cat 1 classification, if such effects are observed 
in the majority of the animals tested, i.e. in 2 out of 3, 3 out 
of 4, 3 out of 5 or 4 out of 6 animals.
In order to be successful in the task of replacing animal 
testing, it is of utmost importance to recognise that ani-
mal reference methods are not perfect and to investigate 
and consider their limitations in the assessment of in vitro 
alternatives. Thus, the uncertainties associated with these 
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animal tests and their benchmark data should be taken 
into account when evaluating/validating alternative meth-
ods and/or strategies developed to replace them. In this 
paper, we show that due to animal-to-animal within-test 
variability, there is an overall probability of at least 11 % 
that chemicals classified as Cat 1 by the in vivo Draize eye 
test under UN GHS/EU CLP could be equally identified 
as Cat 2. We also show that due to this inherent within-
test variability, about 12 % of the Cat 2 chemicals could 
be equally identified as No Cat by the in vivo Draize eye 
test. Importantly, these probabilities may certainly increase 
if the within- and between-laboratory variabilities are also 
considered (Weil and Scala 1971; Marzulli and Ruggles 
1973; Cormier et al. 1996). The in vivo misclassification 
estimates presented here should therefore be acknowledged 
in the development of alternative test methods and testing 
strategies for serious eye damage/eye irritation and should 
also be considered when defining acceptance levels of 
false negatives and false positives during their evaluation/
validation and, most importantly, during their regulatory 
acceptance.
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